Download Files:
Ranibizumab
Price range: 525 CAD through 2,208 CAD
Products Details
Product Description
– Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab’s ability to selectively target and neutralize VEGF-A isoforms has made it a crucial component of research and treatment strategies for wet wet age-related macular degeneration (AMD).
Web ID
– T9928
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Klettner A, et al.Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4523-7.
CAS Number
– 347396-82-1
Molecular Weight
Compound Purity
– 97.6% (SDS-PAGE); 98.22% (SEC-HPLC)
Pathway
– Angiogenesis|||Tyrosine Kinase/Adaptors
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
